Cargando…

P.0403 Disticnt effects of SSRIs therapy in patients with the first episode of major depressive disorder/generalized anxiety disorder after COVID-19 disease

Detalles Bibliográficos
Autores principales:	Bereza, Z., Micale, V., Drago, F., Fedotova, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716274/ http://dx.doi.org/10.1016/j.euroneuro.2021.10.376

Ejemplares similares

SSRIs treatment did not completely restore affective state in patients with the initial clinically confirmed major depressive disorder/generalized anxiety disorder after COVID-19 disease
por: Fedotova, J., et al.
Publicado: (2022)

Resveratrol supplementation enhanced SSRIs efficacy in premenopausal women with major depressive disorder
por: Fedotova, J., et al.
Publicado: (2023)

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
por: Zhang, Aixia, et al.
Publicado: (2022)

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report
por: Park, Young-Min, et al.
Publicado: (2012)

Effect of SSRIs on Resting-State Functional Brain Networks in Adolescents with Major Depressive Disorder
por: Chu, Shu-Hsien, et al.
Publicado: (2021)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

Major Depressive Episode and Generalized Anxiety Disorder Among Sexual Minority Adults in the United States
por: Exten, Cara, et al.
Publicado: (2020)

Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study
por: Beyazyüz, Murat, et al.
Publicado: (2013)

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
por: Liu, Xianchen, et al.
Publicado: (2011)

Disorder-specific cognitive profiles in major depressive disorder and generalized anxiety disorder
por: Hendriks, Sanne M, et al.
Publicado: (2014)

A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs
por: Zhang, Yifan, et al.
Publicado: (2015)

Association of Subclinical Hypothyroidism With Anxiety Symptom in Young First-Episode and Drug-Naïve Patients With Major Depressive Disorder
por: Yang, Ruchang, et al.
Publicado: (2022)

Bidirectional Association between First-Episode Panic Disorder and Major Depressive Disorder in a Nationwide General Population Survey in Korea
por: Woo, Jungmin, et al.
Publicado: (2019)

Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019)

Predictors of social anxiety disorder with major depressive episodes among Japanese university students
por: Watanabe, Shinya, et al.
Publicado: (2021)

Decisional capacity in young people with first episode psychosis, major depressive disorder and no mental disorder
por: Killey, Chiara M.J., et al.
Publicado: (2021)

Are Worry and Rumination Specific Pathways Linking Neuroticism and Symptoms of Anxiety and Depression in Patients with Generalized Anxiety Disorder, Major Depressive Disorder and Mixed Anxiety-Depressive Disorder?
por: Merino, Hipólito, et al.
Publicado: (2016)

Regional increases of cortical thickness in untreated, first-episode major depressive disorder
por: Qiu, L, et al.
Publicado: (2014)

Abnormalities in Electroencephalographic Microstates Among Adolescents With First Episode Major Depressive Disorder
por: He, Yuqiong, et al.
Publicado: (2021)

Alterations of brainstem volume in patients with first-episode and recurrent major depressive disorder
por: Chen, Yue, et al.
Publicado: (2023)

Data on the impact of SSRIs and depression symptoms on the neural activities in obsessive–compulsive disorder at rest
por: Chen, Yunhui, et al.
Publicado: (2016)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Hemolacria secondary to major depressive disorder and generalized anxiety disorder: A case report
por: Razeghian Jahromi, Leila, et al.
Publicado: (2023)

Repetitive Transcranial Magnetic Stimulation Combined with Anti-depressants for the First Episode of Major Depressive Disorder
por: Maneeton, Benchalak, et al.
Publicado: (2020)

Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study
por: Wu, Shengwei, et al.
Publicado: (2021)

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023)

The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder
por: Lu, Yi, et al.
Publicado: (2016)

Brain structural correlates of recurrence following the first episode in patients with major depressive disorder
por: Lemke, Hannah, et al.
Publicado: (2022)

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder
por: Watanabe, Keita, et al.
Publicado: (2022)

Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder
por: Zhou, Yongjie, et al.
Publicado: (2017)

Evaluation of depression and anxiety control in greek patients with major depressive disorder with/without generalized anxiety disorder and cardiovascular disease–pronoi study
por: Papanastasiou, P., et al.
Publicado: (2021)

Gender differences in the association between anxiety symptoms and thyroid hormones in young patients with first-episode and drug naïve major depressive disorder
por: Zhao, Ying, et al.
Publicado: (2023)

Decreased Intrinsic Functional Connectivity in First-Episode, Drug-Naive Adolescents With Generalized Anxiety Disorder
por: Yang, Fan, et al.
Publicado: (2019)

Does Age at Onset of First Major Depressive Episode Indicate the Subtype of Major Depressive Disorder?: The Clinical Research Center for Depression Study
por: Park, Seon-Cheol, et al.
Publicado: (2014)

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
por: Zvěřová, Martina, et al.
Publicado: (2019)

Decreased Functional Connectivity in Insular Subregions in Depressive Episodes of Bipolar Disorder and Major Depressive Disorder
por: Yin, Zhiyang, et al.
Publicado: (2018)

Acupuncture combined with SSRIs in the treatment of perimenopausal depressive disorder: A protocol for systematic review and meta-analysis
por: Gao, Zhan, et al.
Publicado: (2022)

High-field magnetic resonance imaging of structural alterations in first-episode, drug-naive patients with major depressive disorder
por: Chen, Z, et al.
Publicado: (2016)

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pg91i0dl6tuihhmpegdqebcsp9